dc.contributor.author |
Arustamyan G. |
|
dc.contributor.author |
Yegorov E. |
|
dc.contributor.author |
Lipsky S. |
|
dc.contributor.author |
Razumovskaya E. |
|
dc.contributor.author |
Gimranova L. |
|
dc.date.accessioned |
2018-09-18T20:26:37Z |
|
dc.date.available |
2018-09-18T20:26:37Z |
|
dc.date.issued |
2013 |
|
dc.identifier.issn |
1818-4952 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/139930 |
|
dc.description.abstract |
The increasing costs of public health and a growing demand for high-level medicine require the development of efficient economic methods of evaluation and quality management. This article proves that the Clinical and Economic Analysis (C&EA) is the most efficient in terms of cost-benefits. Furthermore, the article defines the role of C&EA by using the principles of evidence-based medicine. A comparative study of the Russian and European experience of C&EA is carried out, with an emphasis on Russian healthcare problems. The article concludes that a modernized C&EA methodology should be introduced, taking into account the European - particularly the French - model of healthcare. © IDOSI Publications, 2013. |
|
dc.relation.ispartofseries |
World Applied Sciences Journal |
|
dc.subject |
Clinical and economic Analysishealthcare quality |
|
dc.subject |
Comparative efficiency |
|
dc.subject |
Efficiency evaluation methods |
|
dc.subject |
Medical and economic standards |
|
dc.subject |
Quality management |
|
dc.title |
Clinical and economic analysis and its role in healthcare quality management |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
3 |
|
dc.relation.ispartofseries-volume |
27 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
318 |
|
dc.source.id |
SCOPUS18184952-2013-27-3-SID84890337464 |
|